Validation of an anti-α-Gal IgE fluoroenzyme-immunoassay for the screening of patients at risk of severe anaphylaxis to cetuximab

Peer Review reports

Original Submission
2 Nov 2022	Submitted	Original manuscript
Resubmission - Version 2
	Submitted	Manuscript version 2
24 Nov 2022	Reviewed	Reviewer Report - Eishin Morita
8 Dec 2022	Reviewed	Reviewer Report
20 Dec 2022	Author responded	Author comments - Brigitte LE MAUFF
Resubmission - Version 3
20 Dec 2022	Submitted	Manuscript version 3
27 Dec 2022	Reviewed	Reviewer Report
31 Dec 2022	Reviewed	Reviewer Report - Eishin Morita
Resubmission - Version 4
	Submitted	Manuscript version 4
Publishing
2 Jan 2023	Editorially accepted
9 Jan 2023	Article published	10.1186/s12885-023-10501-5

Back to article page